Course
Schedule II Controlled Substances and Neonatal Abstinence Syndrome
Pharmacology Contact Hours Awarded:
Start Course
Now
Course Overview
Author: Edith Fomuso
MSN RN CCM DPM
This course is designed for Certified Nurse Midwives who wish to furnish Schedule II Controlled Substances or just want to learn more about their use. The pharmacokinetic and pharmacodynamic principles regarding Schedule II drugs and the risks of neonatal abstinence syndrome will be discussed, as well as the ethical and legal requirements associated with their use.
Course Outline
- Introduction
- Schedule II Controlled Substances and Women’s Health
- Overview of Schedule II Controlled Substances
- Significance of Using Schedule II controlled substances in Pharmacotherapeutic Management of Women’s Health
- Rationale for Using Schedule II Controlled Substances Outside Acute Care Hospitals.
- Pharmacokinetics and Pharmacodynamics of Schedule II Controlled Substances
- Pharmacokinetics
- Pharmacodynamics
- Application of Pharmacokinetic and Pharmacodynamic Principles to Women’s Health Conditions.
- Addiction and Neonatal Abstinence Syndrome
- Understanding Addiction
- Understanding Neonatal Abstinence Syndrome (NAS)
- Preventive Strategies for Addiction and Neonatal Abstinence Syndrome
- Holistic Approach to Addressing Addiction and Neonatal Abstinence Syndrome (NAS)
- Legal Framework for Dispensing Controlled Substances
- Federal and State Regulations on Controlled Substances.
- Dispensing Vs. Administering: Understanding the Difference
- Nurse-midwife’s Role in Ensuring Compliance with Legal Requirements
- Patient-Specific Protocols
- Importance of Patient-specific Protocols in Schedule II Controlled Substance Use
- Components of Patient-Specific Protocols
- Conclusion
Accreditation Statement
Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In this course, we will discuss California Schedule II Controlled Substances and Neonatal Abstinence Syndrome. It will take the average learner 120 minutes to complete and awards contact hours of continuing education.
Course Outcomes
After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:
- Demonstrate an understanding of the pharmacokinetics and pharmacodynamics related to Schedule II controlled substances in relation to women’s health and neonatal care.
- Analyze state laws and federal regulations about furnishing, dispensing, and administering Schedule II controlled substances for out-of-hospital patient use.
- Outline the required components of a furnishing standardized procedure or protocol for Schedule II controlled substances.
Target Audience
- Registered Nurses (RN)
- Advanced Practice Registered Nurses (APRN)
- Licensed Practical Nurses (LPN/LVN)
Requirement for Completion
- Enrollment in the course by the learner
- Read and learn all course materials
- Complete the course evaluation
- Attest and testify learning of the course materials
Accreditations + Approvals
- American Nurses Credentialing Center (ANCC) (P0614)
- California Board of Registered Nursing (CEP 17418)
- Kentucky Board of Nursing (7-0090)
- Louisiana State Board of Nursing (58)
- New York State Department of Education (IC 208)
- New York State Department of Education Child Abuse #80996
- Florida Board of Nursing (50-23983)
Disclosure of Relevant Financial Relationships
Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.
Start Course
Now
Course Expires on: February 12, 2027
Course Offering: #304